Breast Cancer Clinical Trial

Intensive Combo Chemo With Autologous BM Rescue for Metastatic Breast Cancer

Summary

To determine the therapeutic efficacy of high-dose cyclophosphamide and BCNU with autologous bone marrow transplantation after initial tumor cytoreduction for patients with receptor-negative metastatic breast carcinoma and to determine the optimal timing of CyBCNU-ABMT after initial development of metastatic breast carcinoma

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

breast carcinoma at first clinical evidence of metastatic disease
must have measurable disease by physical exam, x-ray, or scan
Age < or equal to 55
performance status 0-2

Exclusion Criteria:

can't have had more than one prior chemotherapy regimen
can't have had concurrent hormonal therapy
no brain metastases
no previous pelvic radiation
no history of another malignancy

Study is for people with:

Breast Cancer

Phase:

Phase 2

Estimated Enrollment:

21

Study ID:

NCT00584766

Recruitment Status:

Completed

Sponsor:

University of Oklahoma

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Oklahoma Health Sciences Center
Oklahoma City Oklahoma, 73104, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 2

Estimated Enrollment:

21

Study ID:

NCT00584766

Recruitment Status:

Completed

Sponsor:


University of Oklahoma

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider